BE885793A - Sels d'acides 6,7-dihalo-3,4-dihydro-3-oxo-2-quinoxalinecarboxyliques et d'amines steriquement encombrees, leur preparation et leur utilisation therapeutique - Google Patents

Sels d'acides 6,7-dihalo-3,4-dihydro-3-oxo-2-quinoxalinecarboxyliques et d'amines steriquement encombrees, leur preparation et leur utilisation therapeutique

Info

Publication number
BE885793A
BE885793A BE1/9993A BE1009993A BE885793A BE 885793 A BE885793 A BE 885793A BE 1/9993 A BE1/9993 A BE 1/9993A BE 1009993 A BE1009993 A BE 1009993A BE 885793 A BE885793 A BE 885793A
Authority
BE
Belgium
Prior art keywords
dihalo
sterically
dihydro
oxo
amines
Prior art date
Application number
BE1/9993A
Other languages
English (en)
Inventor
R F Abdulla
D C Delong
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BE885793A publication Critical patent/BE885793A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C07C205/12Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/96Spiro-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/18Systems containing only non-condensed rings with a ring being at least seven-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/36Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/70Ring systems containing bridged rings containing three rings containing only six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/70Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74Adamantanes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/76Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
BE1/9993A 1979-10-25 1980-10-20 Sels d'acides 6,7-dihalo-3,4-dihydro-3-oxo-2-quinoxalinecarboxyliques et d'amines steriquement encombrees, leur preparation et leur utilisation therapeutique BE885793A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/088,275 US4252954A (en) 1979-10-25 1979-10-25 Salts of dihalo-3,4-dihydro-3-oxo-2-quinoxaline carboxylic acids and hindered amines

Publications (1)

Publication Number Publication Date
BE885793A true BE885793A (fr) 1981-04-21

Family

ID=22210429

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/9993A BE885793A (fr) 1979-10-25 1980-10-20 Sels d'acides 6,7-dihalo-3,4-dihydro-3-oxo-2-quinoxalinecarboxyliques et d'amines steriquement encombrees, leur preparation et leur utilisation therapeutique

Country Status (20)

Country Link
US (1) US4252954A (fr)
EP (1) EP0029658A1 (fr)
JP (1) JPS5681569A (fr)
AU (1) AU6351280A (fr)
BE (1) BE885793A (fr)
CA (1) CA1149381A (fr)
CS (1) CS212304B2 (fr)
DD (1) DD153689A5 (fr)
DK (1) DK449780A (fr)
ES (1) ES8205207A1 (fr)
FI (1) FI803294L (fr)
FR (1) FR2467848A1 (fr)
GB (1) GB2061936A (fr)
GR (1) GR69994B (fr)
IL (1) IL61313A0 (fr)
IT (1) IT1134009B (fr)
PL (1) PL227421A1 (fr)
PT (1) PT71939B (fr)
YU (1) YU268880A (fr)
ZA (1) ZA806437B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD281614A5 (de) * 1988-09-02 1990-08-15 Univ Berlin Humboldt Verfahren zur herstellung von virostatisch wirksamendiazinsubstituierten 1-adamantanen
WO1992011245A1 (fr) * 1990-12-20 1992-07-09 Warner-Lambert Company Derives 2-acylamido de 3,4-dihydro-3-oxo-quinoxaline possedant une activite pharmaceutique
AU744540B2 (en) * 1997-09-01 2002-02-28 Kyorin Pharmaceutical Co. Ltd. 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof, and processes for the preparation of both
US20050026844A1 (en) 2003-04-03 2005-02-03 Regents Of The University Of California Inhibitors for the soluble epoxide hydrolase
CA2559665A1 (fr) 2004-03-16 2005-09-29 The Regents Of The University Of California Reduction de la nephropathie au moyen d'inhibiteurs d'hydrolase d'epoxyde soluble et d'epoxyeicosanoides
CA2584342C (fr) * 2004-10-20 2013-04-30 The Regents Of The University Of California Inhibiteurs ameliores de l'epoxyde hydrolase soluble
TW200808723A (en) 2006-03-13 2008-02-16 Univ California Conformationally restricted urea inhibitors of soluble epoxide hydrolase
US9296693B2 (en) 2010-01-29 2016-03-29 The Regents Of The University Of California Acyl piperidine inhibitors of soluble epoxide hydrolase
JP2013543500A (ja) * 2010-10-08 2013-12-05 ノバルティス アーゲー スルファミドns3阻害剤の塩類および多形
JP6406159B2 (ja) 2015-08-04 2018-10-17 株式会社デンソー 車載表示制御装置、車載表示制御方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3355355A (en) * 1965-02-05 1967-11-28 Smith Kline French Lab Antiviral cycloalkylamine compositions and method
DE1770697C3 (de) * 1967-07-06 1981-04-23 Dupher International Research B.V., Weesp 2,2-(N-Methyl-2-azatetramethylen)- -adamantan, dessen Salze, Verfahren zu deren Herstellung und Arzneimittel
GB1438349A (en) * 1973-09-13 1976-06-03 Post Office Conductor assemblies for cables
US4181724A (en) * 1978-09-11 1980-01-01 The Upjohn Company Quinoxalinone compounds useful for expanding the lumina or air passages in mammals
PH15791A (en) * 1978-10-20 1983-03-25 Lilly Co Eli Pharmaceutical composition containing 3,4-dihydro-3-oxoquinoxalines

Also Published As

Publication number Publication date
ES496210A0 (es) 1981-10-01
GR69994B (fr) 1982-07-23
PT71939A (en) 1980-11-01
FI803294L (fi) 1981-04-26
ZA806437B (en) 1982-05-26
ES8205207A1 (es) 1981-10-01
DD153689A5 (de) 1982-01-27
GB2061936A (en) 1981-05-20
PT71939B (en) 1981-08-31
CA1149381A (fr) 1983-07-05
US4252954A (en) 1981-02-24
CS212304B2 (en) 1982-03-26
FR2467848A1 (fr) 1981-04-30
IT8025538A0 (it) 1980-10-23
IL61313A0 (en) 1980-12-31
EP0029658A1 (fr) 1981-06-03
JPS5681569A (en) 1981-07-03
DK449780A (da) 1981-04-26
IT1134009B (it) 1986-07-24
AU6351280A (en) 1981-04-30
PL227421A1 (fr) 1981-06-19
YU268880A (en) 1983-02-28

Similar Documents

Publication Publication Date Title
FR2487349B1 (fr) Derives de l'hydronaphtalene, leur preparation et leur utilisation en therapeutique
LU81458A1 (fr) Phenethanolamines et leur utilisation therapeutique
BE864112A (fr) Derives d'acide benzoique, leur procede de preparation et leur application en therapeutique
BE856278A (fr) Nouveaux derives d'acide penicillanique et leur utilisation therapeutique
BE882764A (fr) Derives d'acide peneme-3-carboxylique, leurs procedes de preparation et leur application en therapeutique
BE885793A (fr) Sels d'acides 6,7-dihalo-3,4-dihydro-3-oxo-2-quinoxalinecarboxyliques et d'amines steriquement encombrees, leur preparation et leur utilisation therapeutique
BE882166A (fr) 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique
BE857994A (fr) Acides dihydro-oxo-nicotiniques leur preparation et leur application en therapeutique
BE886678A (fr) Tetrapeptides homologues des enkephalines, leur preparation et leur utilisation therapeutique
BE886679A (fr) Tetrapeptides homologues des enkephalines, leur preparation et leur utilisation therapeutique
BE886676A (fr) Pentapeptides homologues d'enkephalines, leur preparation et leur utilisation therapeutique
BE865816A (fr) Derives d'acide benzoique, leur procede de preparation et leur application therapeutique.
BE880615A (fr) Nouveau derive du paracetamol, son procede de preparation et son utilisation en therapeutique
BE865032A (fr) Nouveaux acides uree-bis (naphtalene-sulfoniques et naphtalene-carboxyliques), leurs sels pharmaceutiquement acceptables, et leur utilisation therapeutique
LU81440A1 (fr) Octahydro-2h-pyrrolo(3,4-g)quinoleines et leur utilisation therapeutique
MA19965A1 (fr) 3',5'-diarabinosides, leur preparation et leur application en therapeutique
LU81437A1 (fr) 2-azaergolines et 2-aza-8(ou 9)ergolenes et leur utilisation therapeutique
BE868570A (fr) Derives d'acides tetranaphtalenesulfoniques, leur preparation et leurs utilisations therapeutiques
BE883766A (fr) Anilides d'acides furanne-2-carboxyliques substitues, leur preparation et leurs utilisations therapeutiques
LU80731A1 (fr) Derives d'acides thioalcanoylalcanoiques et leur utilisation therapeutique
BE882167A (fr) (1,1-biphenyl-2-yl)-propyl- et butylamines, leur preparation et leur utilisation therapeutique
LU81350A1 (fr) Arylalkyl-et aryloxyalkyl-phosphonates,leur preparation et leur utilisation therapeutique
FR2549835B1 (fr) Acides peneme-carboxyliques, leur preparation et leur utilisation therapeutique, notamment en tant qu'agents antibacteriens
IT1141082B (it) Reagente e metodo per determinare l'aldolasi di tipo muscolare umano
FR2606409B1 (fr) Derives d'imidazopyridine, leur preparation et leur application en therapeutique